These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38358905)

  • 21. Mixing Studies in Patients With Prolonged Activated Partial Thromboplastin Time or Prothrombin Time.
    Benzon HT; Park M; McCarthy RJ; Kendall MC; Lindholm PF
    Anesth Analg; 2019 Jun; 128(6):1089-1096. PubMed ID: 31094773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A simple and accurate microplate assay for the determination of factor XI in plasma.
    Scott CF; Colman RW
    J Lab Clin Med; 1988 Jun; 111(6):708-14. PubMed ID: 3373114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Applying index of circulating anticoagulant to mixing tests with lupus anticoagulant screen and confirm reagents can distinguish with high specificity between lupus anticoagulants and direct factor Xa inhibitors.
    Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
    Int J Lab Hematol; 2021 Aug; 43(4):771-778. PubMed ID: 33974363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lupus-like circulating anticoagulant or antifactor? Preoperative difficult diagnosis].
    Martin-Toutain I; Vu T; Azgui Z; Piot MT; Jung M; Ankri A
    Ann Biol Clin (Paris); 2004; 62(4):451-5. PubMed ID: 15297241
    [No Abstract]   [Full Text] [Related]  

  • 25. An 89-Year-Old Man with COVID-19-Associated Coagulopathy Presenting with a Prolonged Partial Thromboplastin Time, Lupus Anticoagulant, and a High Titer of Factor VIII Inhibitor.
    Ghafouri S; Rettig M; Kahlon KS
    Am J Case Rep; 2020 Oct; 21():e926728. PubMed ID: 33122620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Factor XI deficiency: actuality and review of the literature].
    Demoy M; Labrousse J; Grand F; Moyrand S; Tuffigo M; Lamarche S; Macchi L
    Ann Biol Clin (Paris); 2024 Jun; 82(2):225-236. PubMed ID: 38702892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgM anticoagulant with acquired abnormalities in factor VIII.
    Andes WA
    Thromb Res; 1982 Sep; 27(6):703-12. PubMed ID: 6817451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of a severe factor XI deficiency in patient undergoing hemodialysis without the use of heparin.
    Takamizawa Y; Araki M; Yoshida N; Yoshioka T; Miura K
    Blood Coagul Fibrinolysis; 2014 Dec; 25(8):898-9. PubMed ID: 24914741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lupus anticoagulant after measles.
    Muntean W; Petek W
    Eur J Pediatr; 1980 Aug; 134(2):135-8. PubMed ID: 6777164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical importance of positive test results for lupus anticoagulant and anticardiolipin antibodies.
    Proven A; Bartlett RP; Moder KG; Chang-Miller A; Cardel LK; Heit JA; Homburger HA; Petterson TM; Christianson TJ; Nichols WL
    Mayo Clin Proc; 2004 Apr; 79(4):467-75. PubMed ID: 15065611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant.
    Sakakura M; Wada H; Watanabe R; Mamamuro M; Okugawa Y; Nakasaki T; Nakase T; Wakita Y; Minamikawa K; Mori Y; Nshikawa M; Shiku H
    Clin Appl Thromb Hemost; 2000 Jul; 6(3):144-50. PubMed ID: 10898274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating anticoagulant against factor XI in psoriasis.
    Rustgi RN; LaDuca FM; Tourbaf KD
    J Med; 1982; 13(4):289-301. PubMed ID: 6957528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between factor XI coagulant and factor XI antigenic activity in cattle.
    Gentry PA
    Can J Comp Med; 1984 Jan; 48(1):58-62. PubMed ID: 6713258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Rare Cause of Isolated Prolonged Activated Partial Thromboplastin Time: An Overview of Prekallikrein Deficiency and the Contact System.
    Riano I; Prasongdee K
    J Investig Med High Impact Case Rep; 2021; 9():23247096211012187. PubMed ID: 33940978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied.
    Moore GW; Savidge GF
    Thromb Res; 2006; 118(4):523-8. PubMed ID: 16263154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Isolated increased aPTT with anamnestic hemorrhagic diathesis--severe FXI deficiency].
    Redondo M; Solenthaler M; Zeerleder S; Wuillemin WA
    Ther Umsch; 1999 Sep; 56(9):502-4. PubMed ID: 10517119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquired factor XI deficiency in systemic lupus erythematosus.
    Vercellotti GM; Mosher DF
    Thromb Haemost; 1982 Dec; 48(3):250-2. PubMed ID: 7164014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The responsiveness of different APTT reagents to mild factor VIII, IX and XI deficiencies.
    Bowyer A; Kitchen S; Makris M
    Int J Lab Hematol; 2011 Apr; 33(2):154-8. PubMed ID: 20840376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activated partial thromboplastin time reagents: an evaluation.
    Howarth S
    Br J Biomed Sci; 1993 Jun; 50(2):109-13. PubMed ID: 8219915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Life-threatening bleeding in a patient with a lupus inhibitor and probable acquired factor VII deficiency.
    Lim S; Zuha R; Burt T; Chacko J; Scott R; Mainwaring CJ
    Blood Coagul Fibrinolysis; 2006 Nov; 17(8):667-71. PubMed ID: 17102654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.